TARGIN

This brand name is authorized in Australia, Austria, Brazil, Canada, Germany, Hong Kong SAR China, Ireland, Israel, New Zealand, Poland, Singapore, Spain.

Active ingredients

The drug TARGIN contains a combination of these active pharmaceutical ingredients (APIs):

1	Oxycodone UNII C1ENJ2TE6C - OXYCODONE HYDROCHLORIDE
	Oxycodone is a full opioid agonist with no antagonist properties. It has an affinity for kappa, mu and delta opioid receptors in the brain and spinal cord. Oxycodone is similar to morphine in its action. The therapeutic effect is mainly analgesic, anxiolytic, antitussive and sedative.
	Read more about Oxycodone
2	Naloxone UNII F850569PQR - NALOXONE HYDROCHLORIDE
	Naloxone hydrochloride, a semisynthetic morphine derivative (N-allyl-nor-oxymorphone), is a specific opioid antagonist that acts competitively at opioid receptors. It reveals very high affinity for the opioid receptor sites and therefore displaces both opioid agonists and partial antagonists, such as pentazocine, for example, but also nalorphine.
	Read more about Naloxone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TARGIN Prolonged-release tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02AA55	Oxycodone and naloxone	N Nervous system → N02 Analgesics → N02A Opioids → N02AA Natural opium alkaloids
Discover more medicines within N02AA55

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10757E, 10758F, 10776E, 11102H, 11111T, 12471J, 12475N, 12486E, 12498T, 12511L, 12522C, 12523D, 12532N, 12540B, 8000C, 8934F, 8935G, 8936H
BR	Câmara de Regulação do Mercado de Medicamentos	556719050002005, 556719050002105, 556719050002205, 556719050002305, 556719050002405, 556719050002505, 556719050002605, 556719050002705, 556719050002805, 556719050002905, 556719050003005, 556719050003105, 556719050003205, 556719050003305, 556719050003405, 556719050003505
CA	Health Products and Food Branch	02339609, 02339617, 02339625, 02387425
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00082914, 00082920, 00082937, 00082966, 00082972, 00082989, 00084184, 00084221, 00084238, 00294415, 00294421, 00294444, 00696160, 00696177, 00696183, 03450011, 03450028, 03450034, 03450063, 03450100, 03450117, 06199853, 06300217, 08750568, 08750640, 08750657, 09065455, 09065461, 09065478, 09065484, 09065490, 09065521, 10146124, 10146130, 10146147, 10146153, 10146176, 10146182, 10146199, 10146207, 10146213, 10177751, 10177768, 10177774, 10177780, 10177797, 10177805, 10177828, 10177834, 10177840, 10177857, 10177863, 10326292, 10326300, 10326323, 10326346, 10326352, 10326369, 10326375, 10326412, 10326429, 11048576, 11149018, 11149053, 11149082, 11149107, 12448912, 12448929, 12448935, 12448941, 12475613, 12475642, 12475659, 12509967, 12509996, 12510002, 12646204, 12646233, 12646256, 12646285, 12646291, 12646316, 14141810, 14146144, 14146167, 14146173
ES	Centro de información online de medicamentos de la AEMPS	71124, 71125, 71126, 71127
HK	Department of Health Drug Office	62554, 62555, 62556, 62557
IE	Health Products Regulatory Authority	42165, 46554, 62849, 62850, 62880, 62881, 62885, 62886
IL	מִשְׂרַד הַבְּרִיאוּת	6234, 6235, 6523, 6524, 8694
NZ	Medicines and Medical Devices Safety Authority	13767, 13777, 13778, 13779
PL	Rejestru Produktów Leczniczych	100218411, 100218428, 100218457, 100218486
SG	Health Sciences Authority	14031P, 14032P, 14033P, 14034P, 15560P, 15561P